Literature DB >> 25598846

Challenges and strategies for identifying biomarkers for colorectal cancer.

Bruno Conte1, Scott Kopetz1.   

Abstract

Entities:  

Year:  2013        PMID： 25598846      PMCID： PMC4296726          DOI： 10.2217/crc.13.65

Source DB:  PubMed          Journal:  Colorectal Cancer        ISSN： 1758-194X


× No keyword cloud information.
  14 in total

1.  Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

Authors:  Paul B Chapman; Axel Hauschild; Caroline Robert; John B Haanen; Paolo Ascierto; James Larkin; Reinhard Dummer; Claus Garbe; Alessandro Testori; Michele Maio; David Hogg; Paul Lorigan; Celeste Lebbe; Thomas Jouary; Dirk Schadendorf; Antoni Ribas; Steven J O'Day; Jeffrey A Sosman; John M Kirkwood; Alexander M M Eggermont; Brigitte Dreno; Keith Nolop; Jiang Li; Betty Nelson; Jeannie Hou; Richard J Lee; Keith T Flaherty; Grant A McArthur
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

2.  Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.

Authors:  Ramon Salazar; Paul Roepman; Gabriel Capella; Victor Moreno; Iris Simon; Christa Dreezen; Adriana Lopez-Doriga; Cristina Santos; Corrie Marijnen; Johan Westerga; Sjoerd Bruin; David Kerr; Peter Kuppen; Cornelis van de Velde; Hans Morreau; Loes Van Velthuysen; Annuska M Glas; Laura J Van't Veer; Rob Tollenaar
Journal:  J Clin Oncol       Date:  2010-11-22       Impact factor: 44.544

3.  Lessons learned from the investigational device exemption review of Children's Oncology Group trial AAML1031.

Authors:  Soheil Meshinchi; Stephen P Hunger; Richard Aplenc; Peter C Adamson; J Milburn Jessup
Journal:  Clin Cancer Res       Date:  2012-03-15       Impact factor: 12.531

4.  Hurdles and complexities of codon 13 KRAS mutations.

Authors:  Maria Pia Morelli; Scott Kopetz
Journal:  J Clin Oncol       Date:  2012-08-27       Impact factor: 44.544

Review 5.  Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancer.

Authors:  Uzma Asghar; Eliza Hawkes; David Cunningham
Journal:  Clin Colorectal Cancer       Date:  2010-12       Impact factor: 4.481

Review 6.  Building a personalized medicine infrastructure at a major cancer center.

Authors:  Funda Meric-Bernstam; Carol Farhangfar; John Mendelsohn; Gordon B Mills
Journal:  J Clin Oncol       Date:  2013-04-15       Impact factor: 44.544

Review 7.  "Right drug for the right patient": hurdles and the path forward in colorectal cancer.

Authors:  Scott Kopetz
Journal:  Am Soc Clin Oncol Educ Book       Date:  2013

8.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

9.  The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.

Authors:  Luis A Diaz; Richard T Williams; Jian Wu; Isaac Kinde; J Randolph Hecht; Jordan Berlin; Benjamin Allen; Ivana Bozic; Johannes G Reiter; Martin A Nowak; Kenneth W Kinzler; Kelly S Oliner; Bert Vogelstein
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

10.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.